Wilmington Funds Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Wilmington Funds Management’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$55K	Buy	+13,440	New	+$57.1K	0.01%	728

Other funds holding SGYP

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WSA

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wilmington Funds Management's SGYP Position: Q2 2014 in Review

Wilmington Funds Management opened a new position in Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2014: 13,440 shares worth $55K. The stake represents 0.01% of the portfolio and ranks #728 among its holdings.

86 funds tracked by Wall St. Rank hold SGYP as of Q2 2014.

Wilmington Funds Management held 13,440 shares of Synergy Pharmaceuticals, Inc Common Stock worth $55K as of Q2 2014.
Synergy Pharmaceuticals, Inc Common Stock was a new Wilmington Funds Management position in Q2 2014.
Synergy Pharmaceuticals, Inc Common Stock made up 0.01% of Wilmington Funds Management's portfolio in Q2 2014, its #728 holding.
86 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.